Your browser doesn't support javascript.
loading
Characterizing and Overriding the Structural Mechanism of the Quizartinib-Resistant FLT3 "Gatekeeper" F691L Mutation with PLX3397.
Smith, Catherine C; Zhang, Chao; Lin, Kimberly C; Lasater, Elisabeth A; Zhang, Ying; Massi, Evan; Damon, Lauren E; Pendleton, Matthew; Bashir, Ali; Sebra, Robert; Perl, Alexander; Kasarskis, Andrew; Shellooe, Rafe; Tsang, Garson; Carias, Heidi; Powell, Ben; Burton, Elizabeth A; Matusow, Bernice; Zhang, Jiazhong; Spevak, Wayne; Ibrahim, Prabha N; Le, Mai H; Hsu, Henry H; Habets, Gaston; West, Brian L; Bollag, Gideon; Shah, Neil P.
Afiliação
  • Smith CC; Division of Hematology/Oncology, University of California, San Francisco, California. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California.
  • Zhang C; Plexxikon Inc., Berkeley, California.
  • Lin KC; Division of Hematology/Oncology, University of California, San Francisco, California.
  • Lasater EA; Division of Hematology/Oncology, University of California, San Francisco, California.
  • Zhang Y; Plexxikon Inc., Berkeley, California.
  • Massi E; Division of Hematology/Oncology, University of California, San Francisco, California.
  • Damon LE; Division of Hematology/Oncology, University of California, San Francisco, California.
  • Pendleton M; Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York.
  • Bashir A; Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York.
  • Sebra R; Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York.
  • Perl A; Abramson Cancer Center of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Kasarskis A; Icahn Institute for Genomics and Multiscale Biology, Mount Sinai School of Medicine, New York, New York.
  • Shellooe R; Plexxikon Inc., Berkeley, California.
  • Tsang G; Plexxikon Inc., Berkeley, California.
  • Carias H; Plexxikon Inc., Berkeley, California.
  • Powell B; Plexxikon Inc., Berkeley, California.
  • Burton EA; Plexxikon Inc., Berkeley, California.
  • Matusow B; Plexxikon Inc., Berkeley, California.
  • Zhang J; Plexxikon Inc., Berkeley, California.
  • Spevak W; Plexxikon Inc., Berkeley, California.
  • Ibrahim PN; Plexxikon Inc., Berkeley, California.
  • Le MH; Plexxikon Inc., Berkeley, California.
  • Hsu HH; Plexxikon Inc., Berkeley, California.
  • Habets G; Plexxikon Inc., Berkeley, California.
  • West BL; Plexxikon Inc., Berkeley, California.
  • Bollag G; Plexxikon Inc., Berkeley, California.
  • Shah NP; Division of Hematology/Oncology, University of California, San Francisco, California. Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, California. nshah@medicine.ucsf.edu.
Cancer Discov ; 5(6): 668-79, 2015 Jun.
Article em En | MEDLINE | ID: mdl-25847190
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirróis / Resistencia a Medicamentos Antineoplásicos / Benzotiazóis / Tirosina Quinase 3 Semelhante a fms / Aminopiridinas / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2015 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Assunto principal: Compostos de Fenilureia / Pirróis / Resistencia a Medicamentos Antineoplásicos / Benzotiazóis / Tirosina Quinase 3 Semelhante a fms / Aminopiridinas / Mutação Limite: Animals / Humans Idioma: En Revista: Cancer Discov Ano de publicação: 2015 Tipo de documento: Article